Biotechnology

The stock performance of Eli Lilly and Company (NYSE: LLY) has been exceptionally good this year, with the pharma giant…

Eli Lilly and Company (NYSE: LLY) on Tuesday reported higher earnings and revenues for the third quarter of 2022. The…

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) Q3 2022 earnings call dated Oct. 27, 2022 Corporate Participants: Susie Lisa -- Senior Vice President, Investor…

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) Q3 2022 earnings call dated Oct. 26, 2022 Corporate Participants: Traci McCarty -- Vice President of Investor…

Pharmaceutical company AbbVie, Inc. (NYSE: ABBV) reported a sharp increase in third-quarter adjusted earnings. The bottom line topped expectations, while…

Merck & Co., Inc. (NYSE: MRK) reported a modest increase in adjusted earnings for the third quarter of 2022 when…

Biogen Inc. (NASDAQ: BIIB) has been going through a rough patch for some time as the company's popular products faced…

Bristol Myers Squibb (NYSE: BMY) reported revenues of $11.2 billion for the third quarter of 2022, down 3% from the…

IPO activity has started gaining steam after falling significantly in the first half, in line with the global trend, but…

Jaguar Health, Inc. (NASDAQ: JAGX) Q2 2022 earnings call dated Aug. 22, 2022 Corporate Participants: Lisa Conte -- Founder & Chief Executive…

Bio Path Holdings Inc.  (NASDAQ: BPTH) Q2 2022 earnings call dated Aug. 16, 2022 Corporate Participants: WIll O'Connor -- Managing Director Peter…

Veru Inc.  (NASDAQ: VERU) Q3 2022 earnings call dated Aug. 11, 2022 Corporate Participants: Samuel Fisch -- Executive Director, Investor Relations &…

CATALYST PHARMACEUTICALS INC (NASDAQ: CPRX) Q2 2022 earnings call dated Aug. 10, 2022 Corporate Participants: Alicia Grande -- Chief Financial Officer Patrick J.…

Cara Therapeutics , Inc. (NASDAQ: CARA) Q2 2022 earnings call dated Aug. 08, 2022 Corporate Participants: Iris Francesconi -- Chief Strategy Officer…

FibroGen, Inc.  (NASDAQ: FGEN) Q2 2022 earnings call dated Aug. 08, 2022 Corporate Participants: Michael Tung -- Vice President of Corporate Strategy…

Moderna, Inc. (NASDAQ: MRNA) Q1 2022 earnings call dated Aug. 03, 2022 Corporate Participants: Lavina Talukdar -- Senior Vice President and Head…

Regeneron Pharmaceuticals Inc.  (NASDAQ: REGN) Q2 2022 earnings call dated Aug. 03, 2022 Corporate Participants: Ryan Crowe -- Vice President of Investor…

Sage Therapeutics, Inc. (NASDAQ: SAGE) Q2 2022 earnings call dated Aug. 02, 2022 Corporate Participants: Helen Rubinstein -- Director of Investor Relations…

ImmunoGen, Inc. (NASDAQ: IMGN) Q2 2022 earnings call dated Jul. 29, 2022 Corporate Participants: Anabel Chan -- Head of Investor Relations Mark…

Biogen Inc. (NASDAQ: BIIB) reported second quarter 2022 earnings results today. Total revenue decreased 7% year-over-year to $2.58 billion. Net…

Biopharmaceutical firm AbbVie Inc. (NYSE: ABBV) is currently at a crucial juncture as it strives to overcome the threat from…